Testosterone
AndroGel, Natesto, Testim, Testopel, Vogelxo, XYOSTED
Androgen
NADAC/unit
$0.4420
No Shortage
Tier 1: 121.6%
PA Req: 512.8%
14 Manufacturers
28 ANDAs
INDICATIONS AND USAGE MALES Androgens are indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. a.
vs. brand AndroGel: Generic saves up to 96% per unit
Market Intelligence
2025-12-10 Class III Recall: Teva Pharmaceuticals USA, Inc
2025-04-02 Class II Recall: Strides Pharma, Inc.
2025-04-02 Class II Recall: Strides Pharma, Inc.
2024-08-28 Class II Recall: Teva Pharmaceuticals USA, Inc
2023-12-06 Class III Recall: Teva Pharmaceuticals USA, Inc
Generic Manufacturers
ACERUS PHARMACEUTICALS CORPACTAVIS LABORATORIES UT INCACTAVIS LABORATORIES UT INC INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCAMNEAL PHARMACEUTICALS LLCANTARES PHARMA INCBESINS HEALTHCARE IRELAND LTDCIPLA LTDENCUBE ETHICALS PRIVATE LTDENDO OPERATIONS LTDEUGIA PHARMA SPECIALITIES LTDHIKMA FARMACEUTICA PORTUGAL SALUPIN INCLUPIN LTDNEXUS PHARMACEUTICALS LLCPADAGIS ISRAEL PHARMACEUTICALS LTDSTRIDES PHARMA INTERNATIONAL AGUPSHER SMITH LABORATORIES LLCXIROMED PHARMA ESPANA SL
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.